News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nassif David W.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2022 |
4
| Nassif David W. (Interim CEO, CFO) has filed a Form 4 on Sio Gene Therapies Inc.|
Txns:
| Granted 546,500 restricted stock units
@ $0 |
|
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Nassif David W. (Principal Financial Officer) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 15,060 shares
@ $0
Paid exercise price by delivering 5,266 shares
@ $3.25, valued at
$17.1k
Disposed/sold 15,060 restricted stock units
@ $0 |
|
| 04/17/2020 |
4
| Nassif David W. (Principal Financial Officer) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 78,900 options to buy
@ $3.45, valued at
$272.2k
Granted 52,600 restricted stock units
@ $0 |
|
| 09/24/2019 |
4
| Nassif David W. (Principal Financial Officer) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 30,120 restricted stock units
@ $0 |
|
| 07/02/2019 |
4
| Nassif David W. (Principal Financial Officer) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 150,000 options to buy
@ $6.42, valued at
$963k
Granted 75,000 options to buy
@ $6.42, valued at
$481.5k
|
|
| 09/04/2018 |
4
| Nassif David W. (EVP and CFO) has filed a Form 4 on SteadyMed Ltd.|
Txns:
| Sold 22,157 shares
@ $4.46, valued at
$98.8k
Disposed of 3,100 options to buy
@ $3.61, valued at
$11.2k
Disposed of 159,642 options to buy
@ $3.61, valued at
$576.3k
Disposed of 51,832 options to buy
@ $5.84, valued at
$302.7k
Disposed of 40,000 options to buy
@ $2.74, valued at
$109.6k
Disposed of 15,987 options to buy
@ $3.65, valued at
$58.4k
|
|
| 07/09/2018 |
4
| Nassif David W. (EVP and CFO) has filed a Form 4 on SteadyMed Ltd.|
Txns:
| Sold 12,157 shares
@ $4.5, valued at
$54.7k
|
|
| 07/03/2018 |
4
| Nassif David W. (EVP and CFO) has filed a Form 4 on SteadyMed Ltd.|
Txns:
| Sold 10,001 shares
@ $4.5, valued at
$45k
|
|
| 12/28/2017 |
4
| Nassif David W. (EVP and CFO) has filed a Form 4 on SteadyMed Ltd.|
Txns:
| Granted 15,987 options to buy
@ $3.65, valued at
$58.4k
|
|
| 11/15/2017 |
4
| Nassif David W. (EVP and CFO) has filed a Form 4 on SteadyMed Ltd.|
Txns:
| Granted 44,315 shares
@ $0 |
|
| 07/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|